Medical News

---

• ‘Window for intervention’ to forestall hypertensive cognitive decline
• Interactive booklet boosts parents’ RTI confidence
• Chest wall resection effective for recurrent mesothelioma
• Erlotinib ‘dose-to-rash’ strategy effective in advanced NSCLC
• Chest wall resection effective for recurrent mesothelioma
• Erlotinib ‘dose-to-rash’ strategy effective in advanced NSCLC
• Interactive booklet boosts parents’ RTI confidence
• Fat mass not linked to lung function in children with asthma
• Incision technique shows potential for bladder neck contracture
• Potential dual benefits to tackling LUTS progression risk factors

‘Window for intervention’ to forestall hypertensive cognitive decline Posted: 15 Dec 2013 04:00 PM PST Newly diagnosed hypertension is predictive of cognitive decline in middle-aged individuals and is worse in those with poorly controlled blood pressure, Dutch researchers have found.

Interactive booklet boosts parents’ RTI confidence Posted: 15 Dec 2013 04:00 PM PST An interactive booklet given to parents in primary care can help them to be more knowledgeable and feel more confident about when and when not to consult a doctor for their child's respiratory tract infections.

Chest wall resection effective for recurrent mesothelioma Posted: 15 Dec 2013 04:00 PM PST Salvage chest wall resection could lengthen survival in patients with isolated chest wall recurrence of malignant pleural mesothelioma, research indicates.

Erlotinib ‘dose-to-rash’ strategy effective in advanced NSCLC Posted: 15 Dec 2013 04:00 PM PST Erlotinib as first-line therapy in patients with advanced non-small-cell lung cancer is equivalent to chemotherapy with regard to overall survival, an "all-comers" phase II trial has shown.

Chest wall resection effective for recurrent mesothelioma Posted: 15 Dec 2013 04:00 PM PST Salvage chest wall resection could lengthen survival in patients with isolated chest wall recurrence of malignant pleural mesothelioma, research indicates.

Erlotinib ‘dose-to-rash’ strategy effective in advanced NSCLC Posted: 15 Dec 2013 04:00 PM PST Erlotinib as first-line therapy in patients with advanced non-small-cell lung cancer is equivalent to chemotherapy with regard to overall survival, an "all-comers" phase II trial has shown.

Interactive booklet boosts parents’ RTI confidence Posted: 15 Dec 2013 04:00 PM PST An interactive booklet given to parents in primary care can help them to be more knowledgeable and feel more confident about when and when not to consult a doctor for their child's respiratory tract infections.

Fat mass not linked to lung function in children with asthma Posted: 15 Dec 2013 04:00 PM PST A study suggests that the relationship between body mass and lung function in children with asthma is more nuanced than previously thought.

Incision technique shows potential for bladder neck contracture Posted: 15 Dec 2013 04:00 PM PST A US team reports that deep lateral transurethral incisions are a promising technique for the treatment of recurrent bladder neck contracture in men following prostate surgery.

Potential dual benefits to tackling LUTS progression risk factors Posted: 15 Dec 2013 04:00 PM PST Research shows that several risk factors associated with Type 2 diabetes and cardiovascular disease also predict the progression of storage and voiding lower urinary tract symptoms in men, suggesting that targeting these could have multiple benefits.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610